Global Variability in Administrative Approval Prescription Criteria for Biologic Therapy in Severe Asthma
Regulatory bodies have approved five biologics for severe asthma. However, regional differences in accessibility may limit the global potential for personalized medicine. To compare global differences in ease of access to biologics. In April 2021, national prescription criteria for omalizumab, mepol...
Saved in:
| Published in: | The journal of allergy and clinical immunology in practice (Cambridge, MA) Vol. 10; no. 5; p. 1202 |
|---|---|
| Main Authors: | , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , |
| Format: | Journal Article |
| Language: | English |
| Published: |
United States
01.05.2022
|
| Subjects: | |
| ISSN: | 2213-2201, 2213-2201 |
| Online Access: | Get more information |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Be the first to leave a comment!